Capecitabine

CAS 154361-50-9 27 FDA-DMF suppliersSmall Molecule

Overview

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of various cancers, most notably colorectal and breast cancer. It is a prodrug that is metabolized to 5-fluorouracil, a molecule that inhibits thymidylate synthase, thereby blocking DNA synthesis in rapidly dividing tumor cells.

API suppliers (26)

Suppliers of Capecitabine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Intas Pharmaceuticals Ltd.India2 active DMF
  • DIVI'S LABOTATORIES LTD1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • SHILPA PHARMA LIFESCIENCES LTD1 active DMF
  • TAPI NL BV1 active DMF
  • PHARMAZELL INDIA PRIVATE LTD1 active DMF
  • ARCHIMICA SPA1 active DMF
  • DIVI'S LABOTATORIES LTD1 active DMF
  • DIVI'S LABOTATORIES LTD1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • ARCH PHARMALABS LTD1 active DMF
  • CTX LIFE SCIENCES PVT LTD1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • SHILPA PHARMA LIFESCIENCES LTD1 active DMF
  • PHARMAZELL INDIA PRIVATE LTD1 active DMF
  • ARCHIMICA SPA1 active DMF
  • Cadila Healthcare LimitedIndia
  • SIGNA SA DE CV
  • Cipla USA, Inc.USA
  • MAC CHEM PRODUCTS INDIA PVT LTD
  • JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina
  • Jiangsu Hengrui Medicine Co., Ltd.China
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China
  • APOTEX PHARMACHEM INC
  • MYLAN LABORATORIES LTD

Showing 25 of 26 suppliers — see the full list in the app.

Therapeutic areas

Oncology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.